search
Back to results

Recovery Improved in Covert Stroke With Exercise (RISE-2)

Primary Purpose

Cerebral Small Vessel Diseases

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Stretching Program
Exercise Program
Sponsored by
Sunnybrook Health Sciences Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cerebral Small Vessel Diseases focused on measuring covert stroke, cerebral blood flow, grey matter, attention, executive function, aerobic exercise

Eligibility Criteria

55 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Covert stroke: white matter hyperintensities of presumed vascular origin
  • Ability to walk for 10 minutes without assistance from another person
  • Fluent in English
  • Ability to consent

Exclusion Criteria:

  • Highly fit individuals exercising ≥ 150 minutes per week
  • Dementia
  • Multiple Sclerosis
  • Disabling stroke (ischemic or hemorrhagic)
  • Major concurrent illness (e.g. chronic obstructive lung disorder, current or metastatic cancer, chronic kidney disease)
  • Major psychiatric illness (e.g. bipolar, schizophrenia, major depression)
  • Contraindications to MRI scanning (e.g. claustrophobia, implants, prostheses, metallic fragments)
  • Contraindications to exercise (participants must have medical clearance to exercise from their attending physician)
  • Recent change in health status (e.g. hospitalization within past month)

Sites / Locations

  • Sunnybrook Health Sciences Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Exercise

Stretching

Arm Description

This group will perform the 'Exercise Program' for months 0 to 6, and will be unsupervised for months 7 to 12.

This group will perform the 'Stretching Program' for months 0 to 6, and the 'Exercise Program' for months 7 to 12.

Outcomes

Primary Outcome Measures

Change in cerebral blood flow from baseline to 6 months
Pseudo-continuous arterial spin labeling MRI
Change in brain structure from baseline to 6 months
Cortical and subcortical grey matter density using structural MRI

Secondary Outcome Measures

Change in brain activity related to attention and executive control tasks from baseline to 6 months
Blood oxygenation level dependent MRI

Full Information

First Posted
February 19, 2014
Last Updated
September 17, 2018
Sponsor
Sunnybrook Health Sciences Centre
Collaborators
Toronto Rehabilitation Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02068391
Brief Title
Recovery Improved in Covert Stroke With Exercise
Acronym
RISE-2
Official Title
Achieving Brain Benefits in Covert Stroke Through Aerobic Exercise
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
June 1, 2015 (Actual)
Primary Completion Date
March 7, 2018 (Actual)
Study Completion Date
September 12, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sunnybrook Health Sciences Centre
Collaborators
Toronto Rehabilitation Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Silent ischemic, also known as "covert stroke vascular disease" (CSVD), contributes to neurological deficits that are caused by damage to small blood vessels in the brain. CSVD occurs six to ten times more often that an acute stroke. It is misleading to think, however, that CSVD is an inevitable part of "getting old" because people with CSVD are at high risk of developing an acute stroke or dementia. In fact, people with more CSVD lesion volume are more likely to develop day to day problems in planning, decision-making and speed of thinking. Unfortunately, there are no proven therapies designed to address CSVD. We propose to test whether aerobic exercise is an intervention that can combat CSVD because the disease is fundamentally a blood flow problem that may be improved by aerobic exercise. We will recruit CSVD adults with moderate to severe lesion burden and use magnetic resonance imaging (MRI) to study the brain in terms of structure, perfusion and function. Participants will be randomly assigned to either our established aerobic exercise program or a control stretching program. Both groups will take part in lab exercise sessions, which are designed to monitor progress and assess adherence to the program. The duration and intensity of their exercise will increase as participants progress. We will use activity log books, phone calls and extra "booster" exercise sessions, as needed, to maximize retention and adherence. We aim to show that aerobic exercise increases cerebral blood flow (CBF) in frontal-subcortical grey matter, supports regional tissue growth, and improves cognitive function in CSVD adults with substantial risk of acute stroke and dementia. A positive outcome of this research will provide strong support for additional clinical trials aimed at sustaining cognition and maintaining independent living.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cerebral Small Vessel Diseases
Keywords
covert stroke, cerebral blood flow, grey matter, attention, executive function, aerobic exercise

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
39 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise
Arm Type
Experimental
Arm Description
This group will perform the 'Exercise Program' for months 0 to 6, and will be unsupervised for months 7 to 12.
Arm Title
Stretching
Arm Type
Active Comparator
Arm Description
This group will perform the 'Stretching Program' for months 0 to 6, and the 'Exercise Program' for months 7 to 12.
Intervention Type
Behavioral
Intervention Name(s)
Stretching Program
Intervention Description
The 'Stretching Program' will teach stretching for the upper and lower limbs, and the trunk, as well as breathing exercises for relaxation. Supervised group activities will be performed once per week (45 minutes) and self-directed stretching will be encouraged 4 days per week and monitored by an activity journal. The intensity of stretching and number of stretches will be progressed every 2 weeks. Heart rate and perceived exertion will be monitored. The program will last 6 months.
Intervention Type
Behavioral
Intervention Name(s)
Exercise Program
Intervention Description
The 'Exercise Program' will prescribe specific aerobic exercise to the participants. Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise will be encouraged 4 days per week and monitored by an activity journal. The initial walking prescription will be set at ~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% of peak oxygen uptake. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of peak oxygen uptake and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.
Primary Outcome Measure Information:
Title
Change in cerebral blood flow from baseline to 6 months
Description
Pseudo-continuous arterial spin labeling MRI
Time Frame
6 months
Title
Change in brain structure from baseline to 6 months
Description
Cortical and subcortical grey matter density using structural MRI
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change in brain activity related to attention and executive control tasks from baseline to 6 months
Description
Blood oxygenation level dependent MRI
Time Frame
6 months
Other Pre-specified Outcome Measures:
Title
Change in white matter integrity from baseline to 6 months
Description
Diffusion tensor imaging (DTI) MRI
Time Frame
6 months
Title
Change in aerobic fitness from baseline to 6 months
Description
Peak oxygen uptake
Time Frame
6 months
Title
Change in aerobic fitness from 6 to 12 months
Description
Peak oxygen uptake
Time Frame
12 months
Title
Change in autonomic function from baseline to 6 months
Description
Heart rate variability
Time Frame
6 months
Title
Change in autonomic function from 6 to 12 months
Description
Heart rate variability
Time Frame
12 months
Title
Change in arterial stiffness from baseline to 6 months
Description
Carotid-femoral pulse wave velocity
Time Frame
6 months
Title
Change in arterial stiffness from 6 to 12 months
Description
Carotid-femoral pulse wave velocity
Time Frame
12 months
Title
Change in executive function from baseline to 6 months
Description
Trail Making Test
Time Frame
6 months
Title
Change in executive function from 6 to 12 months
Description
Trail Making Test
Time Frame
12 months
Title
Change in balance from baseline to 6 months
Description
Spatial-temporal synchronization of center of pressure
Time Frame
6 months
Title
Change in balance from 6 to 12 months
Description
Spatial-temporal synchronization of center of pressure
Time Frame
12 months
Title
Change in dual task gait from baseline to 6 months
Description
Comparison of normal gait to gait with verbal math challenge
Time Frame
6 months
Title
Change in dual task gait from 6 to 12 months
Description
Comparison of normal gait to gait with verbal math challenge
Time Frame
12 months
Title
Change in grip strength from baseline to 6 months
Description
Maximum grip strength with dynamometer
Time Frame
6 months
Title
Change in grip strength from 6 to 12 months
Description
Maximum grip strength with dynamometer
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Covert stroke: white matter hyperintensities of presumed vascular origin Ability to walk for 10 minutes without assistance from another person Fluent in English Ability to consent Exclusion Criteria: Highly fit individuals exercising ≥ 150 minutes per week Dementia Multiple Sclerosis Disabling stroke (ischemic or hemorrhagic) Major concurrent illness (e.g. chronic obstructive lung disorder, current or metastatic cancer, chronic kidney disease) Major psychiatric illness (e.g. bipolar, schizophrenia, major depression) Contraindications to MRI scanning (e.g. claustrophobia, implants, prostheses, metallic fragments) Contraindications to exercise (participants must have medical clearance to exercise from their attending physician) Recent change in health status (e.g. hospitalization within past month)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bradley MacIntosh, PhD
Organizational Affiliation
Sunnybrook Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sunnybrook Health Sciences Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Recovery Improved in Covert Stroke With Exercise

We'll reach out to this number within 24 hrs